In an effort to better understand the access challenges across the US, Hims & Hers introduced the GLP-1 Supply Tracker to help more individuals share their experiences and use their voice to ensure the FDA has the information it needs to better support accessible care
Pharma companies are increasingly focused on growing their DTC platforms
Another potential target for NAD+ related therapy includes nicotinic acid/nicotinamide mononucleotide adenylyltransferase (Nmnat)
altered expression of Cyp2e1 or conjugation enzymes 15,16 ) or environmental exposures (alcohol 17 , drugs 14,18 , or microbiome composition 19 )
In addition, experimental studies have shown that the elevation of GSH can inhibit the activation of hepatic stellate cells [33], which is a key driving factor for extracellular matrix deposition and fibrosis, thereby preventing the progression of liver fibrosis [34]
Fiber adds bulk to stool and is More research is needed to confirm the laxative qualities of tomatoes